Capivasertib (AZD5363) is a broad-spectrum AKT inhibitor with inhibitory activity against Akt1, Akt2, and Akt3 (IC50=3/7/7 nM) with oral activity. Capivasertib has antitumor activity for the treatment of breast cancer.
Molecular Weight:
428.92
CAS Number:
[1143532-39-1]
Formula:
C21H25ClN6O2
Target:
mTOR|||Autophagy|||PKA|||Akt
* VAT and and shipping costs not included. Errors and price changes excepted